NLS Pharmaceutics Has Been Notified By The Listing Qualifications Department Of The Nasdaq Stock Market That The Company's Plan To Regain Compliance Submitted On February 23, 2024 Has Been Approved
纳斯达克股票市场上市资格部门已通知NLS Pharmaceutics,该公司于2024年2月23日提交的恢复合规计划已获得批准